# LEUCOVORIN CALCIUM
> **ANDA207241** · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2018-03-14
## Drug
- **FDA Application Number:** ANDA207241
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LEUCOVORIN CALCIUM
- **Generic name:** LEUCOVORIN CALCIUM
- **Active ingredients:** LEUCOVORIN CALCIUM
- **Dosage form:** SOLUTION
- **Route:** INTRAMUSCULAR, INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** FRESENIUS KABI USA
- **Manufacturer:** Fresenius Kabi USA, LLC
- **First approval:** 2018-03-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207241)
---
*AI Analytics · CC0 1.0*